E. Grassi

Optimal Management of Hepatitis C Genotype 2 Chronic Infection

A. Aghemo, M. Colombo, E. Grassi, 2014, Current Hepatology Reports.

Cirrhosis and Rapid Virological Response to Peginterferon Plus Ribavirin Determine Treatment Outcome in HCV-1 IL28B rs12979860 CC Patients

R. De Francesco, C. Cheroni, E. Galmozzi, 2013, BioMed research international.

How to optimize HCV therapy in genotype 2 patients

A. Aghemo, E. Grassi, 2013, Liver international : official journal of the International Association for the Study of the Liver.

An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C.

A. Andriulli, G. Squadrito, A. Craxì, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Limited Utility of ITPA Deficiency to Predict Early Anemia in HCV Patients with Advanced Fibrosis Receiving Telaprevir

Davide Castaldi, Massimo Colombo, E. Galmozzi, 2014, PloS one.

Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon

G. Casazza, P. Bedossa, P. Lampertico, 2016, PloS one.

Clinical management and patient outcomes of acute lower gastrointestinal bleeding. A multicenter, prospective, cohort study.

C. Hassan, C. Spada, A. Amato, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

P1032 LOW ACCURACY OF NON-INVASIVE TESTS FOR ASSESSING RESIDUAL CIRRHOSIS IN HEPATITIS C PATIENTS WITH A SUSTAINED VIROLOGICAL RESPONSE

M. Colombo, A. Aghemo, M. Fraquelli, 2014 .

Low accuracy of non-invasive tests for assessing residual cirrhosis in hepatitis C patients with a sustained virological response

A. Aghemo, M. Colombo, M. Fraquelli, 2014 .